New Delhi, May 16 (IANS) Emcure Pharmaceuticals on Saturday said the United States Food and Drug Administration (US FDA) completed a current Good Manufacturing Practices (cGMP) inspection at its formulations manufacturing facility in Sanand, Ahmedabad, Gujarat, and issued a Form 483 with seven observations.The inspection was conducted between May 6 and May 15, 2026, at the company’s facility located in the G.I.D.C. industrial area in Taluka-Sanand, Ahmedabad. According to the company, the obse…
Trending
- Mirzapur The Movie Review 2026: Explosive Bhaukaal Saga Delivers Nostalgic Thrills
- Romanchakam Movie Review 2026: A Delightful Youthful Romance That Wins Hearts
- Immortal Movie Review 2026: A Bold Bat-Fantasy Horror That Bites Into New Territory
- Yen Ennai Edho Seidhai Movie Review 2026: A Heartfelt Slice-of-Life Triumph Worth Watching
- Jeevan Ya Bheema Con Review 2026: A Wildly Entertaining Mistaken-Identity Caper That Delivers Big Laughs
- Mahaprabhu Jagannath Movie Review 2026: A Divine Animated Triumph Families Will Love
- Gandhari Movie Review 2026: Taapsee Pannu Delivers a Gripping, Unmissable Thriller
- Why Vitamin D Deficiency Is So Common in India (Even With All That Sunshine)